Dr. Flemming is an Associate Professor of Medicine and Public Health Sciences at Queen’s University with clinical training in gastroenterology, hepatology and liver transplantation. After completing her Internal Medicine and Gastroenterology training at Queen’s University, she completed two years of advanced hepatology and a Master’s in Clinical Research at the University of California San Francisco. She is a clinician scientist who leads a research program which leverages Ontario administrative data housed at ICES to evaluate the epidemiology and outcomes of patients with cirrhosis. Her research has been supported by the American Association for the Study of Liver Disease (AASLD), the American Gastroenterological Association (AGA) and the Canadian Donation and Transplantation Research Program. She also serves as the Chair for the Guidelines Committee of the Canadian Association for the Study of Liver Disease (CASL), is a member of the CASL Equity, Diversity and Inclusion committee in addition to being a member of the AASLD Women’s Initiatives Committee.